about
Snake venom PLA2s inhibitors isolated from Brazilian plants: synthetic and natural moleculesStructural, functional, and bioinformatics studies reveal a new snake venom homologue phospholipase A₂ classCrystal structure of a dimeric Ser49- PLA₂-like myotoxic component of the Vipera ammodytes meridionalis venomics reveals determinants of myotoxicity and membrane damaging activityInhibitory Effects of Hydroethanolic Leaf Extracts of Kalanchoe brasiliensis and Kalanchoe pinnata (Crassulaceae) against Local Effects Induced by Bothrops jararaca Snake VenomStructural and phylogenetic studies with MjTX-I reveal a multi-oligomeric toxin--a novel feature in Lys49-PLA2s protein classProgressive Hemorrhage and Myotoxicity Induced by Echis carinatus Venom in Murine Model: Neutralization by Inhibitor Cocktail of N,N,N',N'-Tetrakis (2-Pyridylmethyl) Ethane-1,2-Diamine and SilymarinGlobal Transcriptome Analysis of the Tentacle of the Jellyfish Cyanea capillata Using Deep Sequencing and Expressed Sequence Tags: Insight into the Toxin- and Degenerative Disease-Related TranscriptsToward understanding interfacial activation of secretory phospholipase A2 (PLA2): membrane surface properties and membrane-induced structural changes in the enzyme contribute synergistically to PLA2 activationThe VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity.Modulation of the pharmacological effects of enzymatically-active PLA2 by BTL-2, an isolectin isolated from the Bryothamnion triquetrum red alga.Transcriptomic analysis of the venom gland of the red-headed krait (Bungarus flaviceps) using expressed sequence tagsIsolation of biologically active peptides from the venom of Japanese carpenter bee, Xylocopa appendiculata.Aqueous leaf extract of Jatropha gossypiifolia L. (Euphorbiaceae) inhibits enzymatic and biological actions of Bothrops jararaca snake venom.In vitro neuromuscular activity of snake venoms.Synergism between basic Asp49 and Lys49 phospholipase A2 myotoxins of viperid snake venom in vitro and in vivo.Human antibody fragments specific for Bothrops jararacussu venom reduce the toxicity of other Bothrops sp. venoms.PhTX-II a basic myotoxic phospholipase A₂ from Porthidium hyoprora snake venom, pharmacological characterization and amino acid sequence by mass spectrometry.Molecular cloning and pharmacological properties of an acidic PLA2 from Bothrops pauloensis snake venom.Identification of novel inhibitors of Daboia russelli phospholipase A2 using the combined pharmacophore modeling approach.Structural Basis for the Inhibition of a Phospholipase A2-Like Toxin by Caffeic and Aristolochic Acids.Purification procedure for the isolation of a P-I metalloprotease and an acidic phospholipase A2 from Bothrops atrox snake venom.Inhibition of the Myotoxicity Induced by Bothrops jararacussu Venom and Isolated Phospholipases A2 by Specific Camelid Single-Domain Antibody Fragments.Snake venoms and hemostasis.Unmasking snake venom of Bothrops leucurus: purification and pharmacological and structural characterization of new PLA2 Bleu TX-IIITrigger release liposome systems: local and remote controlled delivery?Molecular understanding of a potential functional link between antimicrobial and amyloid peptides.Active-site mutagenesis of a Lys49-phospholipase A2: biological and membrane-disrupting activities in the absence of catalysis.Engineering the disulphide bond patterns of secretory phospholipases A2 into porcine pancreatic isozyme. The effects on folding, stability and enzymatic properties.Structural determinants of the hyperalgesic activity of myotoxic Lys49-phospholipase A2.Structural Insight into Binding Mode of 9-Hydroxy Aristolochic Acid, Diclofenac and Indomethacin to PLA2.Chemical modifications of PhTX-I myotoxin from Porthidium hyoprora snake venom: effects on structural, enzymatic, and pharmacological properties.Biological and molecular properties of yellow venom of the Amazonian coral snake Micrurus surinamensis.Membrane cholesterol modulates the cytolytic mechanism of myotoxin II, a Lys49 phospholipase A2 homologue from the venom of Bothrops asper.The diversity of bioactive proteins in Australian snake venoms.Mechanisms governing the level of susceptibility of erythrocyte membranes to secretory phospholipase A2.Structural and functional evidence for membrane docking and disruption sites on phospholipase A2-like proteins revealed by complexation with the inhibitor suramin.Crystallization and preliminary X-ray crystallographic studies of a Lys49-phospholipase A2 homologue from Bothrops pirajai venom complexed with rosmarinic acid.Crystal structure of phospholipase PA2-Vb, a protease-activated receptor agonist from the Trimeresurus stejnegeri snake venom.Role of enzymatic activity in muscle damage and cytotoxicity induced by Bothrops asper Asp49 phospholipase A2 myotoxins: are there additional effector mechanisms involved?Crystallization and preliminary X-ray diffraction analysis of three myotoxic phospholipases A2 from Bothrops brazili venom.
P2860
Q26862510-F707ECDB-BB40-41CF-A8D0-F89CA01840E1Q27664737-38968027-C5DC-41AB-AE23-7ABBC538177CQ27677444-2F414089-44C3-49E0-944D-8BAEA35CEA83Q28468501-8EAA83B6-2D83-456A-8E9E-C8E2EEAD3B16Q28485963-46C3135A-9669-41D9-8CE7-C45D740124A1Q28547272-3372B0E9-6988-400D-9AD2-860EEEEB5711Q28607654-1067E328-22F3-4050-BCB7-D9950E8EE2AAQ30447476-0D18E65D-9454-43A5-87F8-FD2E96D4E58DQ33340668-2223D773-014E-4967-AD84-02EF858790C1Q33340860-F26E4C6B-E76E-4C3B-B413-810904211688Q33547183-D9958AE2-72BA-4CD0-8799-3F81E05C3AAFQ33721801-7601297B-0619-4099-A10D-00DDEC363291Q34050788-BC5E77FB-932A-4AD0-A0B1-5DBE55CD456AQ34143135-3C12AF10-1CAE-4C19-A130-34871B79A86DQ34301758-9B2284B4-DD55-4666-B2BD-720B5E1321E6Q34407118-D6DEEB91-145F-4BE0-B2B8-8D954B64CD40Q34584995-10F55488-998C-4C2B-9E56-81B10141C9DEQ35058939-AED47E97-4F9C-4F50-B405-47C50C925407Q35139724-4017C791-8CEA-4F05-B9DE-A4238A1E4944Q35699362-7823130A-79BA-42E1-87AA-DF01C6B3A735Q35951250-B6EFD7A4-0AEF-4DCE-89B5-26E8B504347AQ35974249-25C2939D-9A50-4CD1-95F9-16F47C79BCB3Q36230877-B8305DD4-3F38-4F7A-92C5-96AAD5313232Q36635439-170801A3-37F5-4180-A7E1-6674F521AD22Q37972351-AD8D3B55-D353-40C9-91EB-D25D342CC8E1Q38238202-F54C4552-8ED6-4333-B57A-C0AC608E9677Q38292301-8B8FCFF7-E936-4F87-BAA0-A5079F2F13A7Q38326440-F38E28F2-5C99-4A71-996C-30CB018A4E20Q38959109-BA87BE9A-FBC2-4730-B1F4-CF3CD655995DQ39160525-425A5D2C-9D9A-4802-8FF5-8A5A9F3AE815Q39181882-14B56F77-CA12-4702-A805-931832953D18Q39322028-946B485D-37CA-483A-841E-E3A26D2F92BAQ39555836-ECFCFA62-C603-486D-9B28-EFAAD93CDA4AQ40240066-514B08F9-A430-44B7-A569-FBFC57EB50F3Q40324979-85A0390B-A877-4BB9-BBB9-30D9B22B3320Q40442267-EBB7F4D4-4438-4852-A3DA-1E46328449C3Q40949892-9CEF8874-44B2-4C3A-B6D7-B5B369CA305BQ41758381-091F5378-0C7D-4DAD-A647-A02CCA449894Q41813405-7BD7065A-097D-4261-BCEC-1CFA1DE79E18Q41830483-51747BF3-418E-4132-8EB0-D32DC09C73EC
P2860
description
1996 nî lūn-bûn
@nan
1996 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Phospholipase A2--a structural review.
@ast
Phospholipase A2--a structural review.
@en
type
label
Phospholipase A2--a structural review.
@ast
Phospholipase A2--a structural review.
@en
prefLabel
Phospholipase A2--a structural review.
@ast
Phospholipase A2--a structural review.
@en
P1433
P1476
Phospholipase A2--a structural review.
@en
P2093
P304
P356
10.1016/0041-0101(96)00036-0
P577
1996-08-01T00:00:00Z